Navigation Links
22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Date:10/5/2010

This Symposium, organised jointly by the European Organisation for the Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research, offers the media:

  • Cutting edge information on new cancer drug research and development from experts in Europe, North America, Asia and Australia;
  • Free registration for bona fide media with official press credentials (press card and/or a commissioning letter on headed paper from the editor of the journal/website they represent);
  • All sessions open to journalists;
  • Media centre with free computing, international phones, and internet.

Around 2,200 international experts in cancer research will present and discuss recent advances in the early development of promising new compounds in different stages of pre-clinical and clinical research.

We welcome the media to the Symposium. Copies of the credentials and identification will be requested at the time of registration and when journalists arrive at the Symposium. Business cards are NOT acceptable.

NB: the official language of the symposium is English and all press materials will be in English.

For media registration, a media registration form can be downloaded at: http://www.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2010/News-Media-and-Public-Relations-Policy/page.aspx/2406

Please email it to: Riitta.Kettunen@ecco-org.eu
Tel: +32 2 775 02 05
Fax: +32 2 775 02 00

More information on the programme and hotel accommodation is available on the EORTC-NCI-AACR symposium website at: http://www.ecco-org.eu/

Accommodation:

The Estrel Hotel is the official hotel for EORTC-NCI-AACR 2010.

You are encouraged to book on-line via the Symposium website: www.ecco-org.eu or complete the hotel reservation form found in the Symposium programme at www.ecco-org.eu and return it by fax, email or post to the following address:

Estrel Hotel and Convention Centre
Sonnenallee 225
12057 Berlin - Germany
Tel: +49 (0)30 6831 0
Fax: +49 (0)30 6831 2345
E-mail: reservation@estrel.com

Reservations are made on a first-come, first-served basis and participants are advised to book early.


'/>"/>

Contact: Emma Mason
wordmason@mac.om
ECCO-the European CanCer Organisation
Source:Eurekalert

Related biology news :

1. Stem Cells and International Stem Cell Symposium present annual stem cells award
2. Military medicine symposium to explore regenerative medicine, behavioral health
3. Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium
4. University at Buffalo symposium on in silico methods, high throughput screening
5. American Chemical Society, Council for Chemical Research to hold R&D symposium Aug. 22
6. Ecologists to discuss impacts of mountaintop mining at special ESA symposium
7. Symposium to explore broadening partnerships to spur medical advances for war injuries
8. American Chemical Society symposium on Deepwater Horizon oil spill on Aug. 24
9. Flowers do it, trees do it: Symposium on plant reproduction
10. IRSF lauds record turn-out for annual Rett Syndrome Symposium
11. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology: